Literature DB >> 9272391

Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.

A Ferrara1, C Dos Santos, M Cimbro, G Gialdroni Grassi.   

Abstract

The in vitro activity of combinations of sparfloxacin/oxacillin, sparfloxacin/fosfomycin, and oxacillin/fosfomycin was investigated against 16 methicillin-resistant Staphylococcus aureus (MRSA) isolates and 12 methicillin-resistant Staphylococcus epidermidis (MRSE) isolates moderately resistant to sparfloxacin. Synergic interactions were observed more frequently against MRSE than against MRSA strains. The most effective combination on both species was fosfomycin plus oxacillin, synergistic against ten of 16 MRSA and eight of 12 MRSE strains.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9272391     DOI： 10.1007/bf01708239

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 2.  Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review.

Authors:  G Montay
Journal:  J Antimicrob Chemother       Date:  1996-05       Impact factor: 5.790

3.  Interactions of fosfomycin with other antibiotics.

Authors:  R Daza; M Moreno-López; D Dámaso
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

4.  European Study Group on Antibiotic Breakpoints. Breakpoint determination: sparfloxacin.

Authors:  I Phillips; J Acar; F Baquero; T Bergan; J Degener; A Forsgren; G C Schito; B Wiedemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

5.  Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.

Authors:  D M Shlaes; L Etter; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

6.  Pharmacokinetics of fosfomycin.

Authors:  W M Kirby
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

7.  Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.

Authors:  J A Patel; C T Pachucki; J R Lentino
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

8.  Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.

Authors:  N X Chin; N M Neu; H C Neu
Journal:  Drugs Exp Clin Res       Date:  1986

9.  Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.

Authors:  H Komatsuzawa; J Suzuki; M Sugai; Y Miyake; H Suginaka
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

Review 10.  In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens.

Authors:  F Baquero; R Cantón
Journal:  J Antimicrob Chemother       Date:  1996-05       Impact factor: 5.790
View more
  3 in total

Review 1.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

2.  Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.

Authors:  Antonia C Kastoris; Petros I Rafailidis; Evridiki K Vouloumanou; Ioannis D Gkegkes; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2010-02-26       Impact factor: 2.953

3.  Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases.

Authors:  Gamal Fadl M Gad; Abd El-Ghafar; Ramadan A A El-Domany; Zeinab Shawky Hashem
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.